Form D · Other Health Care
Liora Life Sciences, LLC
Sandy, UT · CIK 0002157034
Offering snapshot reported Oct 1, 2026 · SEC filing
- Reported sold
- $300K Offering amount: $641M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Sep 14, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 1, 2026 | Initial | $300,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-599553
Source: Form D, filed Oct 1, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Liora Mgmt, Llc | Executive |
| William Tanenbaum | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
9561 South 700 East, Suite 202
Sandy, UT, 84070
Sandy, UT, 84070